Manufacturing Capabilities

CorePharma FDA-registered pharmaceutical manufacturing facilities, located in Middlesex, New Jersey, are licensed to manufacture and distribute controlled substances, Class C-II through C-V. Operating under strict cGMP/GLP regulations and current ICH/FDA guidance, these facilities provide a pharmaceutical manufacturing environment where almost one half billion tablets and capsules are currently produced each year.

CorePharma’s ever-expanding manufacturing capabilities currently include:

  • tablets
  • hard-shell gelatin capsules with the capability to bead fill with batch sizes ranging up to 600 Kg
  • low-shear and high-shear granulations
  • direct compression blends
  • functional and non-functional aqueous film coatings

CorePharma has the ability to fill, label and package solid-dose tablets and capsules; additionally, we have established relationships with vendors who specialize in micronization, blister packaging and powder filling. Leveraging these external partnerships, we manufacture solvent-based products using a variety of technologies. In addition, these relationships permit us to handle highly potent compounds or compounds that require containment.

We continually invest in our manufacturing, packaging and testing facilities to improve efficiencies, ensure quality, add capacity and enhance technologies. Our commitment to investing in the future is unwavering.

adidas eqt   | adidas eqt 9317   | adidas eqt adv   | adidas eqt adv 9317   | adidas eqt adv pk   | eqt adv shoes   | eqt adv 93   | eqt adv 9317   | eqt adv black green   | eqt adv pk   |